Corporate News 31-Dec-15
Orchid Chemicals & Pharmaceuticals receives Establishment Inspection Report (EIR) from USFDA
For its formulation manufacturing facility in Sriperumbudur
Orchid Chemicals & Pharmaceuticals announced that Orchid received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai, Sriperumbudur, Kancheepuram District, India. The facility was inspected by USFDA in the month of May 2015.
Previous News
Orchid Pharma consolidated net profit rises 287.75% in the December 2023 quarter
( Results - Announcements 08-Feb-24 17:29 )
Orchid Pharma reports consolidated net loss of Rs 5.39 crore in the September 2022 quarter
( Results - Announcements 15-Nov-22 08:28 )
Orchid Pharma receives ratings action from CARE
( Corporate News - 30-Nov-23 18:51 )
Board of Orchid Pharma approves draft scheme of amalgamation and arrangement
( Corporate News - 17-Dec-21 10:19 )
Orchid Pharma to discuss results
( Corporate News - 10-Aug-21 11:07 )
Orchid Pharma reports standalone net loss of Rs 166.28 crore in the June 2016 quarter
( Results - Announcements 13-Aug-16 17:40 )
Orchid Pharma announces board meeting date
( Corporate News - 07-Aug-19 13:44 )
Orchid Pharma to announce Quarterly Result
( Corporate News - 31-Aug-20 16:53 )
Orchid Chemicals & Pharmaceuticals reports net loss of Rs 60.14 crore in the June 2014 quarter
( Results - Announcements 18-Aug-14 09:29 )
Orchid Pharma slides as PAT slumps 49% YoY in Q4 FY24
( Hot Pursuit - 24-May-24 12:56 )
Orchid Pharma jumps after receiving USFDA nod for Exblifep injections
( Hot Pursuit - 23-Feb-24 16:18 )
Other Stories
Navkar Corporation revises board meeting date
03-Oct-24 09:52
Adani Ports records 14% growth in cargo volumes in September 2024
03-Oct-24 09:37
SignatureGlobal India launches new project in Gurugram
03-Oct-24 09:34
Biocon Biologics refinances debt through USD bonds and syndicated term loan
03-Oct-24 09:29
RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
03-Oct-24 09:26
Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
03-Oct-24 09:23
Transformers & Rectifiers India wins order of Rs 565 cr
03-Oct-24 09:07
Tata Motors records 12% decline in Q2 sales
01-Oct-24 18:04
Tata Motors records 15% decline in September sales
01-Oct-24 17:55
Man Infra set to launch its highly anticipated Vile Parle project
01-Oct-24 17:48
Back
Top
